<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 03 Apr 2026 17:22:01 -0400--><rss version="2.0">
    <channel>
        <title>Tonix Pharmaceuticals Holding Corp. (TNXP) SEC Filings</title>
        <link>https://ir.tonixpharma.com/sec-filings/annual-reports/rss</link>
        <description>Tonix Pharmaceuticals Holding Corp. (TNXP) - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://s3.amazonaws.com/equisolve-dev4/tonixpharma/files/theme/images/logo-sm.png</url>
                <title>Tonix Pharmaceuticals Holding Corp. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005744/0001999371-26-005744.pdf</link>
                <pubDate>Fri, 13 Mar 26 07:41:30 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005744/0001999371-26-005744.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.06, EX-10.51, EX-21.01, EX-23.01, EX-31.01, EX-31.02, EX-32.01]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf</link>
                <pubDate>Thu, 12 Mar 26 17:30:41 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-26-005730/0001999371-26-005730.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-25-002792/0001999371-25-002792.pdf</link>
                <pubDate>Tue, 18 Mar 25 17:30:25 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-25-002792/0001999371-25-002792.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[11 Related Documents: 10-K, EX-4.06, EX-10.56, EX-10.57, EX-19.01, EX-21.01, EX-23.01, EX-31.01, EX-31.02, EX-32.01, EX-97.01]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-25-002786/0001999371-25-002786.pdf</link>
                <pubDate>Tue, 18 Mar 25 16:43:26 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-25-002786/0001999371-25-002786.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual report to security holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-24-004804/0001999371-24-004804.pdf</link>
                <pubDate>Mon, 15 Apr 24 16:49:48 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-24-004804/0001999371-24-004804.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-4.06, EX-19.01, EX-21.01, EX-23.01, EX-31.01, EX-31.02, EX-32.01, EX-97.01]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-24-004297/0001999371-24-004297.pdf</link>
                <pubDate>Mon, 01 Apr 24 16:41:36 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001999371-24-004297/0001999371-24-004297.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual report to security holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-23-004065/0001387131-23-004065.pdf</link>
                <pubDate>Wed, 29 Mar 23 06:08:01 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-23-004065/0001387131-23-004065.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-4.04, EX-21.01, EX-23.01, EX-31.01, EX-31.02, EX-32.01]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-23-003377/0001387131-23-003377.pdf</link>
                <pubDate>Mon, 13 Mar 23 17:27:08 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-23-003377/0001387131-23-003377.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-4.06, EX-21.01, EX-23.01, EX-31.01, EX-31.02, EX-32.01]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-22-003640/0001387131-22-003640.pdf</link>
                <pubDate>Mon, 14 Mar 22 17:13:42 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-22-003640/0001387131-22-003640.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.06, EX-10.28, EX-21.01, EX-23.01, EX-31.01, EX-31.02, EX-32.01]]></description>
                <link>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-21-003550/0001387131-21-003550.pdf</link>
                <pubDate>Mon, 15 Mar 21 16:24:46 -0400</pubDate>
                <guid>https://ir.tonixpharma.com/sec-filings/all-sec-filings/content/0001387131-21-003550/0001387131-21-003550.pdf</guid>
                                                                            </item>
            </channel>
</rss>